Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LENALIDOMIDA STRAGEN 25 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/LENALIDOMIDA STRAGEN 25 MG CAPSULAS DURAS EFG

Approved

STANDARD

LENALIDOMIDA STRAGEN 25 MG CAPSULAS DURAS EFG

Stragen France🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jul 5, 2021
Approval ID: 266e995c3bc197f1
Company: Stragen France
Type: Standard

Approval Details

Approval Id: 266e995c3bc197f1
Drug Cima Aemps Name: LENALIDOMIDA STRAGEN 25 MG CAPSULAS DURAS EFG
Register Number: 86073
Holder Company Name: Stragen France
Marketing Company Name: Stragen France
Holder Company Detail Path: /organization/stragen-france
Marketing Company Detail Path: /organization/stragen-france
Authorization Date: 2021-07-05
Dosage Form: CÁPSULA DURA
Dose: 25 mg
Route Of Administration: VÍA ORAL
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Stragen France
Company Detail Path: /organization/stragen-france

Company Information

Pharmaceutical Company Name: STRAGEN-FRANCE
Country Name: France
City Name: lyon,auvergne rhone alpes,country_fr
Address: 30 RUE EDOUARD NIEUPORT

Active Ingredients

LENALIDOMIDA

25 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 5, 2021

Approval ID

266e995c3bc197f1

Type

Standard

Back to CIMA-AEMPS Approvals